Ramington Pharmaceuticals Private Limited
About Ramington Pharmaceuticals Private Limited
Data last updated:
Ramington Pharmaceuticals Private Limited is a private limited company based in Ambala Cantt, Haryana, India. It operates in the wholesale trading and distribution segment of the trading and commerce sector. It was incorporated on 13 May 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24299HR2016PTC064072. Its GSTIN is 06AAHCR7573F1Z4 (Haryana).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Krishan Dutt and Mamta Mishra.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at H.No. 20 Prabhu Prem Puram P.O Industrial Area Khojkipur, Ambala Cantt, Haryana, India – 133001.
As per the financials filed for FY 2025, the company reported a revenue of ₹16.55 Lakh, a growth of 3% compared to the previous year. For the same year it recorded a net profit of ₹8,300 (net margin 0.5%) and EBITDA of ₹22,800 (EBITDA margin 1.4%). Revenue has grown at a compounded annual rate (CAGR) of 44% over three years and 50% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Ramington Pharmaceuticals Private Limited's registered office is in Ambala Cantt, Haryana. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressH.No. 20 Prabhu Prem Puram P.O Industrial Area Khojkipur, Ambala Cantt, Haryana, India – 133001
- IndustryTrading, Wholesale, Other Wholesale
To see the full contact details of Ramington Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Ramington Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Ramington Pharmaceuticals Private Limited, buy the company report.
Financials of Ramington Pharmaceuticals Private Limited
FY 2025 filings availableRamington Pharmaceuticals Private Limited reported revenue of ₹16.55 Lakh (up 3% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 50% over five years, including 3% growth in the latest year. EBITDA rose 51% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹22,800 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹8,300 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.4% | ||||
| Net Profit Margin | 0.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Ramington Pharmaceuticals Private Limited, buy the company report.
Board of directors of Ramington Pharmaceuticals Private Limited
Ramington Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Krishan Dutt | Director | 14 Jan 2024 | 2 Years 9 Months | Current |
| Mamta Mishra | Director | 13 May 2016 | 10 Years 5 Months | Current |
Peer comparison
Ramington Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Amaresha Pharmaceuticals Private Limited | ₹16.64 Lakh (FY 2024) | 13.0% | Chennai, Tamil Nadu, India | |||
| Rupison Pharmaceuticals Private Limited | ₹16.61 Lakh (FY 2025) | 24.0% | Agra, Uttar Pradesh, India | |||
| Seraphim Pharmaceuticals Private Limited | ₹16.55 Lakh (FY 2025) | -54.0% | New Delhi, Delhi, India | |||
| Ramington Pharmaceuticals Private Limitedthis company | ₹16.55 Lakh (FY 2025) | ₹8,300 | 0.5% | 3.0% | Ambala Cantt, Haryana, India | |
| Altruistic Pharmaceuticals (OPC) Private Limited | ₹16.54 Lakh (FY 2025) | 90.0% | Agra, Uttar Pradesh, India |
To see the full peer comparison of Ramington Pharmaceuticals Private Limited, buy the company report.
Auditor
Ramington Pharmaceuticals Private Limited is audited by VIJAY GUPTA & JAIN for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| VIJAY GUPTA & JAIN | FY 2017 | 009471N |
Shareholding
The shareholding of Ramington Pharmaceuticals Private Limited is on record for FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Foreign institutional investors (FII) | |
| Public | |
| Others |
To see the full shareholding pattern of Ramington Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Ramington Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Ramington Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Ramington Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 06AAHCR7573F1Z4 | Haryana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Ramington Pharmaceuticals Private Limited, buy the company report.
Recent activity
Ramington Pharmaceuticals Private Limited has 4 board changes on record since 2016: 2 appointments and 2 cessations. The latest: Nitish Mishra ceased to be Director on 22 Jan 2024.
Frequently asked questions
Ramington Pharmaceuticals is an active private limited company based in Ambala Cantt, Haryana, India. The company works in wholesale, within the trading industry. It was incorporated on 13 May 2016 (10+ years old) and is registered under CIN U24299HR2016PTC064072.
Ramington Pharmaceuticals has 2 current directors:
- Krishan Dutt - Director
- Mamta Mishra - Director
The latest financial statements of Ramington Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Ramington Pharmaceuticals is 06AAHCR7573F1Z4, registered in Haryana.
The CIN (Corporate Identification Number) of Ramington Pharmaceuticals is U24299HR2016PTC064072. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Ramington Pharmaceuticals was incorporated on 13 May 2016, making it 10+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Ramington Pharmaceuticals by revenue are Amaresha Pharmaceuticals Private Limited, Rupison Pharmaceuticals Private Limited, Seraphim Pharmaceuticals Private Limited, Altruistic Pharmaceuticals (OPC) Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Nitish Mishra ceased to be Director on 22 Jan 2024. Krishan Dutt was appointed as Director on 14 Jan 2024. Chander Kapila Mohan ceased to be Director on 30 Nov 2021. Ramington Pharmaceuticals has 4 board changes on record in total.
The registered office of Ramington Pharmaceuticals is at H.No. 20 Prabhu Prem Puram P.O Industrial Area Khojkipur, Ambala Cantt, Haryana, India – 133001.
Ramington Pharmaceuticals operates in the trading industry, in the wholesale segment.
The compliance status of Ramington Pharmaceuticals is compliant as of 29 September 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
